UPDATE: Important information about Labcorp's response to COVID-19 Read more >>>

News Releases

Date Title and Summary Additional Formats
Mar 23, 2021
Labcorp Business Update
BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 23, 2021-- Labcorp (NYSE: LH), a leading life sciences company, today issued the following statement: Labcorp continues to make progress executing our strategy and capitalizing on the power of our diagnostic and drug development businesses.
Mar 23, 2021
Dr. Marcia Eisenberg, Chief Scientific Officer of Labcorp Diagnostics, Named a Healthcare Businesswoman’s Association Luminary
In Recognition of Her Three Decades as a Researcher, Mentor, and Champion of Women in Science BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 23, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that Marcia Eisenberg , Ph.D., chief scientific officer of Labcorp
Mar 19, 2021
Labcorp Scheduled to Speak at KeyBanc Capital Markets' Life Sciences and MedTech Investor Forum
BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 19, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat at KeyBanc Capital Markets'   Life Sciences and MedTech Investor Forum on
Mar 09, 2021
Labcorp Named to Fast Company’s List of the World’s Most Innovative Companies for 2021
BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 9, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has been named to Fast Company magazine’s list of 2021 Most Innovative Companies. Since 2008, the annual list has been the definitive source for recognizing the
Feb 23, 2021
Labcorp is Scheduled to Speak at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference
BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 23, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference on
Feb 17, 2021
Labcorp Adds High Sensitivity Antigen Test to Screen for Active COVID-19 Infection
Antigen Test Is the Latest Offering by Labcorp to Fight COVID-19 at Every Stage, from Diagnostic Testing to Clinical Trials and Vaccination Services BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 17, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the availability of a
Feb 16, 2021
Amy Summy, Chief Marketing Officer of Labcorp, Named to Forbes’ CMO Next
BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 16, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that Amy Summy , executive vice president and chief marketing officer, was recognized on the 2021 Forbes CMO Next list for her leadership during the COVID-19 crisis, while
Feb 11, 2021
Labcorp Announces 2020 Fourth Quarter and Full Year Results and Provides 2021 Guidance
Revenue: Q4 of $4.5 billion , up from $3.0 billion last year; Full year of $14.0 billion , up from $11.6 billion last year Diluted EPS: Q4 of $9.54 , up from $2.32 last year; Full year of $15.88 , up from $8.35 last year Adjusted EPS: Q4 of $10.56 , up from $2.86 last year; Full year of $23.94 , up
Feb 09, 2021
Labcorp Announces Key Appointments to Oncology Leadership Team
BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 9, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the appointments of Prasanth Reddy , MD, MPH, and Robert Phillips , PhD, to its oncology team, advancing Labcorp’s leadership position and capabilities in cancer diagnosis,
Feb 01, 2021
Labcorp Named to FORTUNE® Magazine’s 2021 ‘World’s Most Admired Companies,’ Making the Annual List for the Third Time
BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 1, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has been named to FORTUNE® magazine's 2021 List of World’s Most Admired Companies, making the annual list for the third time.
Jan 28, 2021
Labcorp Earns 100 Percent on Human Rights Campaign Foundation’s Annual Scorecard on LGBTQ Workplace Equality
Receives Designation as a Best Place to Work for LGBTQ Equality for Fourth Consecutive Year BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 28, 2021-- Labcorp® (NYSE: LH), a leading global life sciences company, today announced that it received a perfect score of 100 percent on the Human Rights Campaign
Jan 19, 2021
Labcorp Appoints Dr. Deborah Ann Sesok-Pizzini as Chief Medical Officer, Labcorp Diagnostics
Industry Leader Will Assume the Role Previously Held by Dr. Dot Adcock Who is Retiring in April BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 19, 2021-- Labcorp , (NYSE: LH), a leading global life sciences company, announced today that Dr. Deborah Ann Sesok-Pizzini has been appointed Chief Medical
Jan 08, 2021
Labcorp to Announce Fourth Quarter and Full Year 2020 Financial Results on February 11, 2021
BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 8, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, will release its fourth quarter and full year 2020 financial results before the market opens on Thursday, Feb. 11, 2021 , and then will host a conference call and webcast beginning at 9:00
Jan 07, 2021
Labcorp Awarded CDC Contract to Study Variants of COVID-19 Virus and Improve Public Health Response
Genomic Sequencing Aims to Help Define Changes in Transmission and Identify New Mutations BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 7, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has been awarded a contract from the Centers for Disease Control and
Jan 06, 2021
Brian Caveney, Chief Medical Officer and President of Labcorp Diagnostics, Named to Modern Healthcare's 100 Most Influential People in Healthcare
BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 6, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that Dr. Brian Caveney , chief medical officer and president of Labcorp Diagnostics , was recognized by Modern Healthcare as one of the 100 most influential people in
Jan 05, 2021
Labcorp Is Scheduled to Virtually Participate at the 39th Annual J.P. Morgan Healthcare Conference
BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 5, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan.